Jern; Sverker Patent Filings

Patent	Date
Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation Grant 11,400,064 - Jern , et al. August 2, 2	2022-08-02
Delayed release pharmaceutical formulations comprising valproic acid, and uses thereof Grant 11,395,808 - Gustafsson , et al. July 26, 2	2022-07-26
Compounds And Methods For Improving Impaired Endogenous Fibrinolysis Using Histone Deacetylase Inhibitors App 20210060014 - Larsson; Pia ; et al.	2021-03-04
Compounds And Compositions For The Treatment Or Prevention Of Pathological Conditions Associated With Excess Fibrin Deposition A App 20200179381 - Bergh; Niklas ; et al.	2020-06-11
Valproic Acid For The Treatment Or Prevention Of Pathological Conditions Associated With Excess Fibrin Deposition And/or Thrombus Formation App 20190015360 - Jern; Sverker ; et al.	2019-01-17
Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation Grant 10,111,845 - Jern , et al. October 30, 2	2018-10-30
Valproic Acid For The Treatment Or Prevention Of Pathological Conditions Associated With Excess Fibrin Deposition And/or Thrombus Formation App 20180177751 - Jern; Sverker ; et al.	2018-06-28
Compounds And Methods For Improving Impaired Endogenous Fibrinolysis Using Histone Deacetylase Inhibitors App 20170020874 - Larsson; Pia ; et al.	2017-01-26
Compounds And Methods For Improving Impaired Endogenous Fibrinolysis Using Histone Deacetylase Inhibitors App 20140051716 - Larsson; Pia ; et al.	2014-02-20

Patent

Date

Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation
Grant 11,400,064 - Jern , et al. August 2, 2

2022-08-02

Delayed release pharmaceutical formulations comprising valproic acid, and uses thereof
Grant 11,395,808 - Gustafsson , et al. July 26, 2

2022-07-26

Compounds And Methods For Improving Impaired Endogenous Fibrinolysis Using Histone Deacetylase Inhibitors
App 20210060014 - Larsson; Pia ; et al.

2021-03-04

Compounds And Compositions For The Treatment Or Prevention Of Pathological Conditions Associated With Excess Fibrin Deposition A
App 20200179381 - Bergh; Niklas ; et al.

2020-06-11

Valproic Acid For The Treatment Or Prevention Of Pathological Conditions Associated With Excess Fibrin Deposition And/or Thrombus Formation
App 20190015360 - Jern; Sverker ; et al.

2019-01-17

Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation
Grant 10,111,845 - Jern , et al. October 30, 2

2018-10-30

Valproic Acid For The Treatment Or Prevention Of Pathological Conditions Associated With Excess Fibrin Deposition And/or Thrombus Formation
App 20180177751 - Jern; Sverker ; et al.

2018-06-28

Compounds And Methods For Improving Impaired Endogenous Fibrinolysis Using Histone Deacetylase Inhibitors
App 20170020874 - Larsson; Pia ; et al.

2017-01-26

Compounds And Methods For Improving Impaired Endogenous Fibrinolysis Using Histone Deacetylase Inhibitors
App 20140051716 - Larsson; Pia ; et al.

2014-02-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

Jern; Sverker

Patent Applications and Registrations